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Carcinomas typically invade as a cohesive multicel-
lular unit, a process termed collective invasion. It
remains unclear howdifferent subpopulationsof can-
cer cells contribute to this process. We developed
three-dimensional (3D) organoid assays to identify
the most invasive cancer cells in primary breast
tumors. Collective invasion was led by specialized
cancer cells that were defined by their expression of
basal epithelial genes, such as cytokeratin-14 (K14)
and p63. Furthermore, K14+ cells led collective inva-
sion in the major human breast cancer subtypes.
Importantly, luminal cancer cells were observed to
convert phenotypically to invasive leaders following
induction of basal epithelial genes. Although only a
minority of cells within luminal tumors expressed
basal epithelial genes, knockdown of either K14 or
p63 was sufficient to block collective invasion. Our
data reveal that heterotypic interactions between
epithelial subpopulations are critical to collective in-
vasion. We suggest that targeting the basal invasive
program could limit metastatic progression.
INTRODUCTION
Invasion is a fundamental step in tumor progression and a driving
force formetastasis. Although invasion is commonly conceptual-
ized as a single-cell process, the majority of solid tumors display
features of collective invasion in which cells invade cohesively as
a multicellular unit (Friedl et al., 2012; Leighton et al., 1960). A
central problem in collective invasion is how a group of adherent
epithelial cancer cells acquires motile invasive behavior (Friedl
and Gilmour, 2009; Gray et al., 2010; Polyak and Weinberg,
2009).
One solution is for cancer cells to rely upon the motility of
migratory stromal cells, such as fibroblasts (Gaggioli et al.,
2007) or macrophages (Condeelis and Pollard, 2006; DeNardo
et al., 2009). However, mammary tumors also contain multipleCsubpopulations of tumor cells with distinct genotypic and pheno-
typic characteristics. Importantly, this cellular heterogeneity is
associated with differences in metastatic potential and thera-
peutic response (Almendro et al., 2013; Fidler, 2003). It remains
unclear how these subpopulations of cancer cells contribute to
collective invasion.
Clinically, the transition from in situ to invasive breast cancer
correlates with a strong reduction in overall survival, but the
molecular basis of this transition has remained elusive (Polyak,
2010). The challenge of transitioning to a motile phenotype is
particularly acute in mammary luminal epithelial cells, as these
cells are normally connected by extensive intercellular junctions
and display less spontaneous motility than myoepithelial cells in
real-time analyses (Ewald et al., 2008). Consistent with this
concept, luminal breast cancers have a more favorable average
prognosis, but 8%–21%of cases eventually metastasize to liver,
lung, or brain (Kennecke et al., 2010). Furthermore, luminal
breast cancer cell lines are weakly invasive in 2D culture
compared to basal subtypes (Neve et al., 2006).
We hypothesize that breast tumors accomplish collective in-
vasion through cell-cell interactions among functionally distinct
epithelial cancer cells within the primary tumor. To test this
hypothesis, we developed 3D organoid assays to identify the
most invasive cancer cells within a primary tumor in an unbiased
fashion. In the present study, we applied these assays to demon-
strate that the cells leading collective invasion are molecularly
and behaviorally distinct from the bulk tumor cells and display
a conserved, basal epithelial gene expression program.
RESULTS
An Ex Vivo 3D Culture Assay Identifies Invasive Cells
within Primary Tumors
We developed a 3D primary culture model (Nguyen-Ngoc et al.,
2012) that enabled us to observe cell behaviors during collective
invasion and to interrogate the molecular phenotype of the most
invasive cells (Figure 1A). Briefly, we isolate fresh primary
tumors and use a combination of mechanical disruption and
enzymatic digestion to generate ‘‘tumor organoids.’’ Tumor
organoids are composed of 200–1,000 adherent tumor cells
and reflect the cellular heterogeneity present in the primaryell 155, 1639–1651, December 19, 2013 ª2013 Elsevier Inc. 1639
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Figure 1. Leaders Cells Are Molecularly
Distinct and Express Basal Epithelial
Markers in a Luminal Mammary Carcinoma
Model
(A) Schema of a leader cell assay. The primary
tumor is digested to tumor organoids, each
composed of 200–1,000 adherent tumor cells, and
embedded in 3D collagen I matrix.
(B) Time-lapse DIC microscopy of a MMTV-PyMT
mouse mammary tumor organoid embedded in
collagen I. Collectively migrating cells emerge
from the tumor organoid. Protrusive leader cells
are readily identified at the front of these invasive
strands. See also Movie S1.
(C–F) Leader cells stained with K14 and phalloidin
(C), p63, K14 and DAPI (D), P-cadherin (Pcad),
K14, and phalloidin (E) or K5 and phalloidin (F).
(G) Frequency of leader cells expressing K14, p63,
K5, K8, K18, E-cadherin (Ecad), SMA, and CNN1 in
MMTV-PyMT tumor organoids. 95% confidence
intervals for each proportion are denoted in
parentheses.
Scale bars, 50 mm in (B) and 20 mm in (C–F). See
also Figure S1.tumor. To study collective invasion, we cultured tumor organo-
ids in 3D collagen I gels, a model for the microenvironment
surrounding invasive breast cancers (Conklin et al., 2011;
Nguyen-Ngoc et al., 2012; Paszek et al., 2005; Provenzano
et al., 2008; Wolf et al., 2009).
We first characterized invasion in organoids derived from a
genetically engineered mouse model of breast cancer in which
the mouse mammary tumor virus long terminal repeat drives
expression of the polyoma virus middle T oncogene (MMTV-
PyMT) (Guy et al., 1992a). MMTV-PyMT mice develop highly
invasive mammary tumors that metastasize spontaneously to
the lung (Lin et al., 2003). By gene expression profiles, MMTV-
PyMT tumors cluster with the aggressive luminal B subtype of
human breast cancer (Herschkowitz et al., 2007). Tumor organo-
ids isolated from this model progressively extended multicellular
strands of cancer cells into the collagen I over 48–72 hr (Figure 1B
and Movie S1 available online). Because the cells leading these
invasive strandswere highly protrusive andmigratory, we refer to
them as ‘‘invasive leader cells’’ (Figure 1B, right).1640 Cell 155, 1639–1651, December 19, 2013 ª2013 Elsevier Inc.Invasive Leader Cells Are
Molecularly Distinct and Express
Basal Epithelial Markers
We were able to determine the molecular
phenotype of invasive leader cells unam-
biguously due to their position at the front
of invasive strands and their distinct pro-
trusive morphology. Our analysis defined
four molecular features of leader cells in
this luminal mouse model. First, leader
cells preferentially expressed multiple
basal epithelial markers, including
cytokeratin-14 (K14), p63, P-cadherin,
and cytokeratin-5 (K5) (Figures 1C–1G).
Among these markers, K14 was themost frequently associated with leader cells (94% of leaders,
n = 1,523 leaders, from 10 mice, CI [93%–95%]). Second, leader
cells coexpressed markers of luminal epithelium, including K8,
K18, and E-cadherin (Figures 1G and S1A–S1C). However,
whereas basal markers were preferentially expressed in leader
cells, K8 and E-cadherin also strongly stained the noninvasive
K14 core of cells within the tumor organoid (Figures S1A and
S1C). Third, leader cells typically did not express markers of
smooth muscle contractility, such as SMA, MYH11, and CNN1
(Figures 1G, and S1D, and S1E) and did not contract in response
to the hormone oxytocin, which induces smooth muscle
contractility (Figures S1F and S1G). Because the smooth muscle
program is a defining feature of myoepithelial cells in the normal
mammary gland, we conclude that invasive leader cells are
distinct frommyoepithelial cells. Fourth, leader cells did not typi-
cally express Twist, Slug, or vimentin (Figure S1H), which are
common markers of a molecular epithelial-mesenchymal transi-
tion (EMT). Finally, leader cells retained membrane localized
E-cadherin at sites of cell-cell contact with follower cells
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Figure 2. K14+ Cells Are Enriched at the
Tumor Invasive Border and in Lung Metas-
tases
(A) Area of tumor invasion into muscle in 100-mm-
thick mammary tumor sections, stained with K14,
DAPI, and phalloidin. T, tumor; K, K14+ leader
cells; M, phalloidin+ muscle fibers.
(B) Collectively invading K14+ leaders at high
magnification stained with K14, phalloidin, SMA,
and DAPI. M, muscle; V, SMA+ vessel; arrow,
leading K14+ cell with forked protrusions. Inset
highlights the chain of three K14+ cells. This
micrograph represents a z-projection of more than
40 mm to capture the organization of the invasive
strand. See Movie S2.
(C) Schema to quantify the percentage of collective
invasion that is led byK14+ cells. mTomato+ tumor
organoids were isolated from MMTV-PyMT;mT/
mG mice. Organoids were transplanted ortho-
topically into nonfluorescent congenic hosts.
Transplanted tumors >1 cm in size were harvested
to generatemontagesof the tumor-stromal border.
(D) Micrograph of a representative mTomato+ tu-
mor-stromal border stained with K14. mTomato+
regions (in red) denote tumor-derived cells. Insets
denotemulticellular groupsof cells invading into the
adjacent stroma. An invasive strandwas defined as
a protrusive group of cells connected to the main
tumor. A nest was defined as an isolated group of
tumor cells. n = 145 invasive strands and n = 83
nests were counted from 13 sections from 5 mice.
95% confidence intervals denoted in parentheses.
The micrograph represents a 40 mm z-projection.
(E–G)Reconstructedmetastases in thicksectionsof
lungs fromMMTV-PyMTmice,stainedwithK14,K8,
and phalloidin. Normal lung parenchyma was K14
negative (E). Both micrometastatic and larger met-
astatic lesions had K14+ and K8+ cells (F and G).
(H) Metastatic lung lesions were identified by K8
positivity and were classified based on their K14
status. Data are presented as mean ± SD. n = 226
metastases from 5 tumor mice. p value was
determined by two-sided t test.
Scale bars, 20 mm in (B and D) and 50 mm in (E–G).
See also Figure S2.(Figure S1C, blue arrows). Taken together, our observations
reveal that invasive leader cells in this luminal breast cancer
model are molecularly distinct from bulk tumor cells and prefer-
entially express K14 and other basal epithelial markers.
K14+ Cells Are Enriched at the Invasive Border in
Primary Tumor and in Lung Metastases
We next asked whether K14+ cells also led collective invasion
in vivo in this luminal model. To address this question, we opti-
cally reconstructed large regions of the tumor-stromal border
from fixed sections of intact tumors. K14+ cells were concen-
trated at tumor-stromal borders (n = 9 reconstructed tumors
from 8 mice; Figure 2A) and led multicellular invasive strands
into the adjacent muscle (Figures 2A and 2B and Movie S2). As
in 3D culture, K14+ cells were negative for SMA and coex-
pressed luminal K8 (Figures 2B and S2A). Thus, K14+ cells
lead collective invasion in 3D culture and in vivo.CWe next asked what fraction of collective invasion in vivo
was led by K14+ cells. We employed an orthotopic transplant
model to mark donor-derived tumor cells unambiguously.
We transplanted MMTV-PyMT mammary tumor organoids
coexpressing a red fluorescent reporter (mTomato) into the
cleared mammary fat pads of nonfluorescent congenic hosts
(FVB) and identified invasive units at the tumor-stromal border,
blind to K14 expression (Figures 2C and 2D). These invasive
units included multicellular groups of cells connected to the
main tumor mass, which we defined as invasive strands, and
groups of cells unconnected from the main tumor mass,
which we defined as tumor nests (Figure 2D, middle). We
then classified each invasive unit—in the case of strands, we
asked whether the leader cells were K14+, and in the case
of nests, we asked whether any cell in the group was K14+.
By this measure, we observed that 88% of invasive strands
and 80% of tumor nests were K14+ (Figure 2D, right). Next,ell 155, 1639–1651, December 19, 2013 ª2013 Elsevier Inc. 1641
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Figure 3. K14+ Cells Lead Collective Invasion across Mouse Models of Breast Cancer and in Primary Human Breast Cancers
(A) Time-lapse DIC microscopy of collagen-I-embedded organoids derived from MMTV-Neu, MMTV-PyMT, or C3(1)/Tag mammary tumors. White bars, leader
cells. See also Movie S3.
(B) Micrographs of leader cells from the three mouse models in (A) stained with K14, SMA, and phalloidin.
(C) Quantification of the number of invasive leaders per tumor organoid in (A). For MMTV-Neu, n = 116 organoids from 4 mice. For MMTV-PyMT, n = 245
organoids from 10 mice. For C3(1)/Tag, n = 104 organoids from 4 mice. Data are presented as mean ± SD. *p < 0.05 and **p < 0.01. p value was determined by
two-sided t test.
(legend continued on next page)
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we systematically quantified the distance of K14+ and K14
cells from the tumor-stromal border in large optically recon-
structed montages (Figures S2E–S2G). We observed strong
enrichment for K14+ cells in the first 100 mm from the stromal
border, whereas K14 cells were relatively uniformly distrib-
uted (n = 5 montages from 4 tumors; Figure S2H). We
conclude that K14+ cancer cells are strongly enriched at the
tumor-stromal interface and lead the majority of collective in-
vasion in vivo.
Because MMTV-PyMT tumors develop metastases with high
penetrance, we next quantified the K14 status of their lung me-
tastases. Although K14 was absent in normal lung parenchyma,
we observed K14 staining in >88% of metastatic lesions, from
micrometastases up to large, 500 mm lesions (Figures 2E–2H).
In contrast, K14+ cells constituted only a small percentage of
the total cell population in the primary tumor (1.4% ± 0.2% by
fluorescence-activated cell sorting [FACS], n = 3 mice; Fig-
ure S2D). Consistent with their phenotype in the primary tumor,
K14+ metastases were negative for SMA in both micrometa-
static and large metastatic lesions (Figures S2B and S2C). We
conclude that, although K14+ cells are rare in the primary tumors
of this luminal breast cancer model, they are strongly enriched in
lung metastases.
K14+ Cells Lead Collective Invasion across Multiple
Mouse Models of Breast Cancer
To test the generality of our observations, we next character-
ized invasion in two additional genetically engineered mouse
models of breast cancer: MMTV-Neu, a model of HER2+
luminal breast cancer, and C3(1)/Tag, a model of basal breast
cancer (Guy et al., 1992b; Maroulakou et al., 1994). Tumor
organoids isolated from these models displayed pronounced
differences in the morphologic patterns and timing of invasion
in 3D culture (Figures 3A and 3B and Movie S3). MMTV-Neu
tumor organoids had the fewest leader cells, MMTV-PyMT
organoids had an intermediate number, and C3(1)/Tag tumor
organoids had the most leader cells (Figures 3C and 3D).
Despite these differences in the frequency of invasion, >80%
of leader cells in all three models were K14+ (Figure 3E). Simi-
larly, the majority of K14+ leader cells coexpressed luminal K8
but did not express SMA in all three models (Figures 3B, 3E,
S3A, and S3B).(D) The percentage of invasive tumor organoids from the three mousemodels in (A
instance of protrusive cell motility into collagen I matrix. n = 22–70 tumor organo
(E) Frequency of leader cells expressing K14 or SMA in MMTV-Neu or C3(1)/Ta
parentheses.
(F) Time-lapse DIC microscopy of a human luminal breast tumor organoid embed
of tumor organoid from same tumor specimen, stained for K14, SMA, and F-act
(G) Pathologic characteristics of harvested human breast tumors, including stag
measured frequency of K14+ leaders. 9 of 10 tumors were ER-positive luminal b
subtype was determined using surrogate immunohistochemistry definitions (Gol
(H) Representative micrograph of a K14+ collective invasion front from an archiv
(I) The distribution of cases according to breast cancer subtype assigned using
(J) The frequency of cases with low (+), medium (++), or high (+++) K14 staining s
Figure S4A.
(K) The distribution of cases according to histologic tumor grade.
(L) The frequency of cases with low (+), medium (++), or high (+++) K14 staining
Scale bar, 50 mm in (A and F) (left movie series), 20 mm in (B and F) (right panel),
CK14+ Cells Lead Collective Invasion in Primary Human
Breast Tumors in 3D Culture and In Vivo
To validate our observations from mouse models, we next
characterized invasive leader cells in fresh human breast tumor
specimens. We isolated organoids from primary tumor tissue
obtained at initial breast surgery (n = 10; Figure 3F) using estab-
lished protocols (Nguyen-Ngoc et al., 2012). We classified each
specimen using surrogate immunohistochemistry definitions
(Goldhirsch et al., 2013). In total, there were nine luminal breast
cancers, five of which were luminal B. In each case, human
tumor organoids invaded into collagen I matrix (Figure 3F and
Movie S3). Although the numbers of invasive strands and
disseminated cells varied among tumor samples, >86% of
leaders expressed K14 across all samples (Figures 3F, 3G, and
S3E). K14+ cells typically coexpressed nuclear p63 (Figure S3C)
and typically did not express SMA (Figures 3F andS3E). A subset
of K14+ cells was also positive for luminal K8 and K18 (Fig-
ure S3D). Together, these data demonstrate that the cells that
lead invasion in 3D culture express basal epithelial markers
across multiple mouse models of breast cancer and in primary
human breast tumors.
We therefore hypothesized that K14+ cells would lead collec-
tive invasion in primary human breast tumors in vivo. We first
examined fixed sections from intact tumor specimens corre-
sponding to three cases from 3D culture. We observed that
K14+ cells led collective invasion in each case (Figure S3F).
We next assayed for K14+ cells in archival specimens of primary
breast tumors (n = 39 specimens) from multiple subtypes of
human breast cancer. Using consensus guidelines, we then
assigned these specimens to breast cancer subtypes based
on their ER, PR, HER2/Neu, and Ki-67 status, as assayed by
immunohistochemistry (Goldhirsch et al., 2013). There were 16
luminal A cases, 17 luminal B cases (including 4 cases with
HER2+ disease), and 6 triple-negative breast carcinomas (Fig-
ure 3I). We stained these samples for K14 using immunohisto-
chemistry and classified their intensity to three levels: low (+),
medium (++), and high (+++) (Figure S4A).
We observed strong K14 staining (CK3) in collective invasive
fronts in luminal A, luminal B (both HER2 and HER2+), and
triple-negative breast cancers (Figures 3H, 3J, and S4D–
S4G). Breast cancer subtype was not statistically significantly
associated with K14 staining intensity (Fisher’s exact test,) as a function of time in culture (in hr). Onset of invasion was defined as the first
ids per mouse model.
g tumor organoids. 95% confidence intervals for each proportion denoted in
ded in collagen I matrix (sample S4). White bar, leader cell. At right, micrograph
in. See also Movie S3.
e, grade, ER status, PR status, HER2/Neu status, Ki-67 percentage, and the
reast tumors, with ER positivity ranging from 20%–100%. The breast cancer
dhirsch et al., 2013).
al specimen classified as luminal B.
surrogate IHC subtype definitions. n = 39 cases in total.
tratified by IHC-defined breast cancer subtype. K14 intensity was scored as in
stratified by tumor grade.
and 100 mm in (H). See also Figures S3 and S4.
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Figure 4. Luminal Tumor Cells Acquire
Markers of Basal Differentiation
(A) Mouse mammary tumor organoids grown in 3D
collagen matrix stained with K8 and K14.
(B) Bar graph of percentage of tumor organoids
with K8 or K14 intensity equal to or greater than
1+ as a function of time. K14 and K8 intensity was
quantified into 0 (no or few), 1 (intermediate), or 2
(bright) K14 signal. Data are presented as mean ±
SD. For K14: n = 719 organoids from 5–8 mice
per day; for K8: n = 269 organoids from 3 mice
per day.
(C) Mammary tumor organoids grown in 3D
collagen matrix stained with p63 and DAPI.
(D) The percentage of organoids with nuclei
positive for p63 was counted. Data are presented
as mean ± SD. n = 114 organoids from 2 mice
per day.
(E) Invasion was quantified by scoring protrusive
morphology of cancer cells in contact with the
ECM. Data are presented as mean ± SD. n = 916
organoids from 4–7 mice per day.
(F) Tumor organoids treated from day 0 with
DMSO vehicle or a mitosis inhibitor (aphidicolin
10 mM) stained with K14, pH3, and DAPI.
(G) The number of pH3+ nuclei per tumor organoid
in vehicle or mitosis inhibitor (aphidicolin)-treated
conditions. Data are presented as boxplots. n = 79
organoids from 2 mice per condition.
(H) K14 intensity scored in vehicle or aphidicolin.
K14 intensity was quantified into 0 (no or few), 1
(intermediate), or 2 (bright) K14 signal. n = 110
organoids from 2 mice per condition.
(I) Time-lapse microscopy of MMTV-PyMT tumor
organoids expressing GFP under the control of the
K14 promoter (K14-GFP), beginning at the start of
culture. See Movie S4.
(J) K14-GFP+ cells migrate collectively and lead
trailing K14-GFP cells. Arrowhead, K14+ leader
cell invasion. See Movie S4.
All p values were determined by two-sided t test.
*p < 0.05. **p < 0.01. ***p < 0.001. Scale bars,
40 mm in (F) and 20 mm in (A,C, I, and J). See also
Figure S5.p = 0.11). We also stratified samples by histologic grade (Fig-
ure 3K). In general, higher histologic grade was associated
with higher K14 staining intensity (Figure 3L, Fisher’s exact
test, p < 1 3 104). However, even among luminal B tumors
with high grade (grade 3), we identified cases with low, me-
dium, and high K14 staining (Figure S4A). We observed three
distinct patterns of K14 staining in human tumors: cytoplasmic
staining, cytoskeletal staining with intense staining bundles of
K14, and a border-enriched pattern, in which staining appeared
specific to cells at the border of the collective invasion front
(Figure S4B). The triple-negative breast cancers showed a sta-
tistically significant increase in cytoskeletal staining pattern
relative to luminal tumors (Figure S4C; Fisher’s exact test,
p < 0.01). Together, these data demonstrate that K14 is ex-
pressed in collective invasion fronts across the major subtypes
of human breast cancer.1644 Cell 155, 1639–1651, December 19, 2013 ª2013 Elsevier Inc.Luminal Tumor Cells Acquire Markers of Basal
Differentiation
To address how K14+ leaders are generated, we asked when
K14 was expressed in 3D culture of MMTV-PyMT tumor organo-
ids. Consistent with the low in vivo frequency of K14+ cells in this
luminal mouse model, tumor organoids were initially K8+, with
few K14+ cells. During the first 48 hr of culture, the number of
K14+ cells and p63+ cells in tumor organoids increased signifi-
cantly (Figures 4A–4D, S5A, and S5B). This expansion in basal
marker positive cells coincided closely in time with the onset of
collective invasion (Figures 4E and S5C). K14+ and p63+ cells
were most frequently observed on the basal surfaces of tumor
organoids in contact with the extracellular matrix (ECM). Thus,
tumor organoids start 3D culture primarily luminal in character
and subsequently expand a population of cells with basal differ-
entiation markers.
One possible cellular mechanism for the expansion of K14+
cells is cell proliferation. However, the number of mitotically
active (pH3+) K14 cells was significantly greater than the
number of mitotically active K14+ cells during the first 2 days
of culture (Figures S5D and S5E). Furthermore, treatment with
aphidicolin blocked mitosis completely but did not prevent an
increase in K14+ cells (Figures 4F–4H). We conclude that prolif-
eration is not required for acquisition of a K14+ cell phenotype.
Alternatively, luminal tumor cells may convert directly from
K14 to K14+ states. To test this hypothesis directly, we gener-
ated MMTV-PyMT mice carrying a K14 promoter biosensor in
which GFP reports on K14 gene expression (Vaezi et al., 2002).
In these tumor organoids, we observed individual cells at the
basal surface transition from K14 to K14+ states (Figure 4I,
cross-sectional view, and S5F, en-face, and Movie S4; n = 22
movies). Following phenotypic conversion, the newly K14+ cells
dynamically extended and retracted membrane protrusions into
the matrix (n = 149 movies) and led migration of trailing GFP
cells (n = 70 movies; Figure 4J and Movie S4). Consistent with
these data in mouse, we observed that organoids derived from
multiple primary human breast tumors similarly expanded their
fraction of K14+ and p63+ cells (Figures S5G–S5I). Taken
together, these data reveal that the invasive leader phenotype
is a differentiation state exhibited by cancer cells, not a fixed
lineage.
K14+Cells Acquire Leader Cell Behaviors Specifically in
Collagen-I-Rich Local Microenvironments
We previously demonstrated that ECM composition strongly
regulates tumor invasion (Nguyen-Ngoc et al., 2012). Organoids
isolated from the same tumor but allocated to different ECMs
robustly invaded when cultured in collagen I, but not when
cultured in basement membrane gels (Matrigel). We therefore
hypothesized that different ECM environments might have a dif-
ferential capacity to induce the basal gene expression character-
istic of invasive leader cells.
To test this hypothesis, we cultured MMTV-PyMT tumor orga-
noids in 3D Matrigel. Although tumor organoids were noninva-
sive in Matrigel (Figures S6A–S6C), we still observed a robust
increase in the number of K14+ tumor cells. At day 0, there
were few K14+ cells, but by day 4, 99% of tumor organoids
had basal K14+ staining (Figures 5A and 5B). As in collagen I,
Matrigel-embedded tumor organoids expressed nuclear p63
and P-cadherin specifically in basally located cells in contact
with ECM and did not express SMA (Figures 5C, 5D, and
S6D). Consistent with these results, we also observed pheno-
typic conversion in K14-GFP;PyMT tumor organoids cultured
in Matrigel (Figure S6E and Movie S5; n = 5 movies). Taken
together, these data demonstrate that induction of the basal
epithelial program does not require collagen I and occurs in
diverse ECM microenvironments.
If phenotypic conversion induces a stable change in invasive
potential, then switching to an invasivemicroenvironment should
induce an acute change in K14+ cell behavior. To test this
hypothesis, we conducted a matrix-swapping experiment. We
cultured PyMT tumor organoids in 3D Matrigel for 4 days, liber-
ated organoids from the gel, and re-embedded them in collagen
I. Under these conditions, there was rapid collective invasionCfrom the basal layer within 12 hr (Figures S6F and S6G andMovie
S6; n = 14 movies). In response to collagen I matrix, individual
K14+ cells at the basal surface became protrusive and subse-
quently initiated collective invasion (Figure S6G, insets). These
findings show that phenotypic conversion and collective inva-
sion are distinct steps and that the latent invasive potential of
K14+ cells is only converted to invasive cell behaviors in specific
tumor microenvironments.
In vivo, we observed that, although K14+ cells led collec-
tive invasion, there were also K14+ cells with noninvasive
morphology (Figure 2A). These findings raised the question of
which factors in vivo distinguish K14+ cells that manifest inva-
sive morphology from those that do not. Because the local
ECM context within a primary tumor is heterogeneous, we hy-
pothesized that differences in invasive morphology in vivo would
correlate with differences in ECM context. Accordingly, we
assayed fibrillar collagen density in fixed thick tumor sections
by second harmonic generation (SHG) and collagen IV density
by immunofluorescence. Areas were classified as having either
invasive or noninvasive morphology based on the protrusive
morphology of the K14+ cells in the region (Figures 5E and
5F). Invasive regions were associated with an 8-fold increase
in median collagen I fiber density relative to noninvasive regions
(Figure 5G). In contrast, collagen IV, a component of basement
membrane and Matrigel, was observed at comparable levels
in both invasive and noninvasive regions (Figure 5H). Taken
together, our data demonstrate that 3D Matrigel and 3D
collagen I ECM microenvironments induce distinct cell mor-
phologies similar to those observed in specific regions of pri-
mary tumors in vivo and suggest that K14+ cells in vivo acquire
leader cell behaviors specifically in collagen-I-rich local
microenvironments.
Basal Epithelial Genes K14 and p63 Are Required for
Collective Invasion in 3D Culture
We next asked whether expression of basal epithelial genes
by leader cells is functionally required for collective invasion.
Accordingly, we developed protocols for efficient lentiviral trans-
duction of primary tumor organoids. We tested five different
small hairpin RNAs (shRNAs) targeting K14 and p63 and deter-
mined the two hairpins with the highest knockdown efficiency
by western blotting (Figures S7A and S7B). As a control, we
used a hairpin that targets luciferase (Luc-kd).
To assess the requirement for K14 in collective invasion, we
cultured Luc-kd, K14-kd1, and K14-kd2 tumor organoids in 3D
collagen I and observed them by time-lapse differential interfer-
ence contrast (DIC) microscopy. Control Luc-kd organoids
strongly expressed K14 and invaded vigorously into collagen I
matrix (Figures 6A–6C and Movie S7). In contrast, both K14
expression and collective invasion were markedly reduced in
K14-kd organoids (Figures 6A, 6B, 6D, and 6F). Although K14-
kd tumor organoids generally lacked multicellular invasive
strands, we still observed subcellular protrusions extending
from K14-kd organoids (Figure 6D, red arrows, and Figure S7C).
We next infected organoids with lentiviruses encoding both
K14-shRNA and GFP to label K14-kd cells in real time.
By tracking infected organoids at single-cell resolution, we
observed individual K14-kd cells that were protrusive and motileell 155, 1639–1651, December 19, 2013 ª2013 Elsevier Inc. 1645
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cellular protrusions but is required for the transition to persistent
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knockdown (p63-kd1 and p63-kd2) in PyMT primary tumor orga-
noids cultured in collagen I (Figures 6A, 6B, 6E, and 6G). We
observed a strong reduction in p63 protein levels and in collec-
tive invasion in p63-kd organoids (Figures 6E, 6G, and S7D).
However, compared with K14-kd organoids, p63-kd organoids
had fewer protrusive cells and more rounded cell borders (Fig-
ures 6E and S7C and Movie S7). Because knockdown with
p63 hairpin abrogated collective invasion but yielded only a par-
tial reduction in K14, these data suggest that p63 has essential
K14-independent functions in collective invasion. In aggregate,
these data demonstrate that multiple basal epithelial genes ex-
pressed by leader cells are individually required for collective in-
vasion in 3D culture. Furthermore, these data show that basal
epithelial genes are required for collective invasion in a luminal
mouse model of breast cancer, despite being expressed in
only a small minority of the tumor cells.
In Vivo Knockdown of K14 Disrupts Collective Invasion
at the Tumor-Stromal Border
We next sought to test the requirement for K14 in collective inva-
sion in vivo. We isolated tumor organoids from fluorescently
labeled advanced carcinomas (mTomato+; MMTV-PyMT),
transduced them with Luc-kd, K14-kd1, or K14-kd2 lentivirus,
and then orthotopically transplanted the transduced organoids
into the cleared mammary fat pads of nonfluorescent congenic
hosts (Figure 7A). Although tumor growth appeared similar, we
observed strong differences in collective invasion at the tumor-
stromal border. In Luc-kd tumors, cells at the tumor stromal
border strongly expressed K14 and organized many K14+
invasive strands and nests of cells (Figure 7B). In contrast, in
K14-kd1 tumors, we observed large regions in which the tumor
stromal border was K14 and lacked either invasive strands or
nests (Figures 7C and 7D). The K14 regions instead displayed
borders with a rounded morphology (Figures 7C and 7D).
Furthermore, whereas fibrillar collagen was associated with col-
lective invasion in control tumors (Figure 5E), in K14-kd1 tumors,
this association was disrupted. Within K14-kd1 tumors, we
observed noninvasive borders that were both K14 and sur-
rounded by dense fibrillar collagen (Figure 7F). To quantify the
differences in collective invasion between knockdown condi-
tions, we determined the number of invasive strands and nests
per tumor section. The number of collective invasive units per
section was significantly reduced in K14-kd1 tumors relative to
Luc-kd control tumors (Figure 7D). Consistent with the less effi-
cient knockdown of K14-kd2 observed by immunofluorescence
and western blotting, we observed a qualitatively similar reduc-
tion in invasive units in K14-kd2 tumors (Figures 7D and 7E).
The residual invasion observed in both K14-kd1 and K14-kd2 tu-
mors was predominantly K14+ and was concentrated in discrete
K14+ tumor foci (Figures 7E and 7G). These data demonstrate
the presence of residual tumor cells competent to express K14
and suggest that, despite puromycin selection prior to transplan-
tation, K14-competent cells preferentially expanded in vivo.
Together, these data demonstrate (1) that K14 is required in vivo
for collective invasion at the tumor-stromal border, (2) that
elevated collagen I is not sufficient to induce collective invasion
in vivo in the absence of K14 expression, and (3) that targeting a
basal invasive program expressed in a small minority of tumor
cells is sufficient to disrupt the invasive process in an advanced
carcinoma.CDISCUSSION
The transition to invasive behavior in epithelial cancer cells is a
critical step in metastasis, yet both the cellular and molecular
basis of this transition is incompletely understood. An important
challenge is that primary tumors are complex heterogeneous tis-
sues containing phenotypically and genetically distinct cancer
cell subpopulations interacting with an altered extracellular ma-
trix and diverse stromal cells (Almendro et al., 2013; Egeblad
et al., 2010a, 2010b; Fidler, 2003; Weigelt and Bissell, 2008). It
is important to reduce this complexity to specific molecular reg-
ulators of tumor cell behavior in order to identify targets for ther-
apeutic intervention.
To accomplish this goal, we developed a general strategy for
identifying the most invasive cells in a primary epithelial tumor.
We then applied this strategy and discovered that the most inva-
sive cancer cells are behaviorally and molecularly distinct from
bulk tumor cells. Importantly, the invasive leader cells expressed
basal epithelial genes, including K14 and p63, across mouse
models of breast cancer and in diverse human breast tumors.
Cells with this phenotype led the majority of collective invasion
in vivo and were strongly overrepresented in lung metastases.
We therefore have exploited our assays to resolve the heteroge-
neous cancer cell populations within the primary tumor into
functional classes based on their invasive behavior. We then
leveraged this understanding to establish the requirement for
K14 and p63 for collective invasion in primary cells derived
from poorly differentiated carcinomas.
Previous studies have shown that heterotypic epithelial-stro-
mal interactions contribute to cancer invasion in diverse malig-
nancies (Condeelis and Pollard, 2006; Gaggioli et al., 2007).
Our data establish the importance of heterotypic epithelial-
epithelial interactions between different cancer cell subpopula-
tions in collective invasion. Importantly, although invasive leader
cells were highly protrusive and migratory, they retained charac-
teristically epithelial expression of cell adhesion proteins (e.g.,
E-cadherin) and intermediate filament proteins (e.g., K14, K8)
during invasion.
K14 expression also marks other highly migratory epithelial
cell populations. During development, the migratory cells of
the normal mammary embryonic placode are K14+K8+SMA
(Moumen et al., 2011; Sun et al., 2010). Similarly, the highly inva-
sive rat breast cancer MTLn3 cell line is K14+K8+, whereas
noninvasive MTCs do not express these markers (Lichtner
et al., 1991). Likewise, highly invasive human breast cancer cell
lines MDA-MB-468, MDA-MB-436, and BPLER are K14+K18+,
whereas cell lines with low invasive potential, such as MCF-7,
T47D, and ZR75 express a pure luminal phenotype (Gordon
et al., 2003; Petrocca et al., 2013). Experimental models suggest
that basal breast cancers arise from luminal progenitors and
that mutations in genetic drivers of breast cancer, such as
BRCA1, can shift luminal progenitors toward basal differentia-
tion (Lim et al., 2009; Molyneux et al., 2010). Consistent with
these observations, a number of pathologic studies have shown
that basal cytokeratins, including K14, are associated with poor
patient prognosis, early relapse, and reduced overall survival (de
Silva Rudland et al., 2011; Gusterson et al., 2005; Laakso et al.,
2006; Malzahn et al., 1998). Our study provides a biological basisell 155, 1639–1651, December 19, 2013 ª2013 Elsevier Inc. 1647
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(A) Micrographs of MMTV-PyMT tumor organoids transduced with lentiviral particles encoding shRNAs against luciferase control (Luc shRNA), K14 (K14
shRNA), or p63 (p63 shRNA) and then embedded in collagen I matrix and stained for K14 and Phalloidin. Left: bracket, leader cell. Middle: blue arrow, K14
protrusive cell.
(B) K14 intensity was quantified into 0 (no or few), 1 (intermediate), or 2 (bright) K14 signal for organoids from (A). n = 61–93 organoids per condition from 3
independent experiments.
(C–E) Time-lapse DICmicroscopy of transduced organoids as in (A). In Luc shRNA transduced organoids, the tumor organoid invades collectively (C). Inset shows
protrusive cells that extend and expand into a collective invasive strand. In K14 shRNA transduced organoids, tumor organoids do not invade collectively (D).
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and rounded cell borders in p63-kd1 tumor organoids. See Movie S7.
(F and G) The number of collective invasive strands in Luc shRNA, K14-shRNA kd1 and kd2, and p63-shRNA kd1 and kd2 transduced organoids was determined
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(legend continued on next page)
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(A) Schema to test the in vivo requirement for K14
in collective invasion. Fluorescent mTomato+
(mT+) tumor organoids were transduced with
either Luc shRNA (Luc-kd) or K14-shRNA (K14-
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rescent congenic FVB hosts. Tumor was isolated
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border were assembled.
(B) Micrograph of the tumor-stromal border from a
representative Luc-kd tumor stained with K14.
mT+ regions (in red), tumor-derived cells. Insets,
collective invasive units in the Luc-kd tumor. The
micrograph represents a z-projection of more than
40 mm.
(C) Micrograph of the tumor-stromal border from a
representative K14-kd1 tumor stained with K14.
mT+ regions (in red), tumor-derived cells. Insets,
representative K14 noninvasive border.
(D) Median number of invasive units per section in
Luc-kd and K14-kd tumors, with data presented
as a boxplot. Invasive units included strands and
nests as described in Figure 2E. p values were
determined by two-sided t test.
(E) Frequency of invasive units expressing K14 in
Luc-kd and K14-kd tumor sections. 95% confi-
dence intervals for each proportion were denoted
in parentheses.
(F) Representative micrograph of K14-kd1 tumor-
stromal border stained for K14 and assayed for
fibrillar collagen by SHG. mT+ regions (in red),
tumor-derived cells.
(G) Micrograph of a K14-kd1 tumor stained with
K14, demonstrating K14+ and K14 tumor foci.
The micrograph represents a z-projection of more
than 40 mm.
Scale bars represent 100 mm in (B and C), 40 mm in
(F), and 1,000 mm in (G).for these findings, namely that K14 marks a subpopulation of
tumor cells capable of initiating collective invasion, a critical
step in metastatic progression.
Importantly, we directly observed phenotypic conversion of
K14 luminal tumor cells to K14+ cells with invasive potential.
We previously demonstrated that collective invasion is strongly
regulated by the composition of the local extracellular matrix
(Nguyen-Ngoc et al., 2012). In the present study, we demon-shRNA kd1 from 5 independent experiments. n = 42 movies for p63 shRNA kd2 from 3 independent experime
determined by two-sided t test. **p < 0.001. ***p < 1 3 1010.
(H) Time-lapse sequence of a representative tumor organoid transduced with lentiviral particles encoding fo
shown in false color purple. Arrows, individual GFP+ (and K14-shRNA-expressing) protrusive cells.
Scale bars, 20 mm in (A), 50 mm in (C–E), and 10 mm in (H). See also Figure S7.
Cell 155, 1639–1651, Destrated that the basal invasive program
can be induced in diverse ECM microen-
vironments. However, consistent with our
prior study, basal gene expression was
only associated with invasive cell behav-iors and morphologies in collagen-I-rich microenvironments in
3D culture and in vivo.
In our study, we established that the basal epithelial interme-
diate filament cytoskeleton is specifically required for collective
invasion in cancer. Our data suggest that actin-based subcellu-
lar protrusions and multicellular collective invasion can be
uncoupled and have distinct cytoskeletal requirements. The pre-
cise mechanism by which cytokeratin 14 regulates collectivents. Data are presented as boxplots. p values were
r dual expression of K14-shRNA and GFP. GFP is
cember 19, 2013 ª2013 Elsevier Inc. 1649
invasion, be it directly modifying the tensile strength and visco-
elastic properties of the cell (Yamada et al., 2002), regulating
cell-cell adhesion (Weber et al., 2012), or by signal transduction
mechanisms independent of their mechanical properties (Kim
et al., 2006), remains unclear and warrants further study.
Because cells with basal differentiation are found inmany epithe-
lial organs, our findingsmay also have implications for invasion in
other solid tumors.
EXPERIMENTAL PROCEDURES
Mouse Lines and Breeding
Mice used in this study were backcrossed onto and maintained on the FVB/n
background in a specific pathogen-free facility. Animal protocols were
approved by the Johns Hopkins IACUC. FVB/N-Tg(MMTV-PyVT)634Mul/J
(MMTV-PyMT) (Guy et al., 1992a), FVB/N-Tg(MMTVneu)202Mul/J
(MMTV-Neu) (Guy et al., 1992b), FVB-Tg(C3-1-TAg)cJeg/JegJ (C3(1)/Tag)
(Maroulakou et al., 1994), and B6.129(Cg)-Gt(ROSA)26Sortm4(ACTB-
tdTomato,-EGFP)Luo/J (mT/mG) (Muzumdar et al., 2007) mice were obtained
from the Jackson Lab. K14-GFP-actin mice (Vaezi et al., 2002) were a
generous gift from Elaine Fuchs (Rockefeller University). For confocal time-
lapse experiments, MMTV-PyMT mice were crossed with mT/mG mice and/
or K14-GFP-actin mice.
Analyses of Fresh Primary Human Tumors
Primary breast cancers were acquired in accordance with IRB exempt proto-
cols NA_00052607 and NA_00077976 (Nguyen-Ngoc et al., 2012). In brief,
each tumor sample was deidentified prior to receipt with limited prespecified
clinical information provided with each sample. The tumor sample was kept
in cold Dulbecco’s modified Eagle’s medium (DMEM) when in transit. The
tumor sample was rinsed with antibiotic wash, minced, and then digested in
collagenase with or without trypsin. Tumor organoids were treated with DNase
and separated out by differential centrifugation at 1,500 rpm 3 4–6 spins.
Tumor organoids were then allocated to either Matrigel or 3D collagen I and
cultured in human mammary epithelium medium containing insulin, EGF,
hydrocortisone, and cholera toxin. Medium was replaced every 3 to 4 days.
Statistics
Statistical analysis was conducted using R. For all boxplots, the whiskers
represent the 5th and 95th percentiles. All tests used and p values are specified
in the figure legends. p < 0.05 was considered significant.
Additional materials and methods, including isolation of tumor organoids,
antibodies, and staining procedures used, are described in the Extended
Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and seven movies and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2013.11.029.
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